|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.720 USD | +0.27% |
|
-8.60% | +85.07% |
| 06-18 | Chardan Raises Price Target on Opus Genetics to $13 From $11, Keeps Buy Rating | MT |
| 06-16 | Opus Genetics, Inc. - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.27% | -8.60% | -12.68% | -21.68% | +85.07% | +283.43% | -4.86% | -26.19% | - | 303M | |
| +0.93% | +2.65% | +5.89% | +23.07% | +4.93% | +42.33% | +145.77% | +389.83% | +1,417.14% | 1,006B | |
| +1.61% | +7.22% | +4.50% | +2.06% | +18.33% | +60.81% | +47.98% | +49.13% | +111.78% | 589B | |
| +3.51% | +12.31% | +12.72% | +17.36% | +6.41% | +31.15% | +78.88% | +115.21% | +306.18% | 430B | |
| +0.99% | +5.11% | +0.24% | +7.47% | +2.16% | +29.26% | +21.27% | -2.76% | +39.13% | 331B | |
| +1.09% | +6.90% | +1.05% | 0.00% | +1.97% | +37.22% | +23.11% | +65.45% | +248.80% | 288B | |
| +1.34% | +6.74% | +5.47% | +5.33% | +14.96% | +32.63% | +38.93% | +48.83% | +66.34% | 285B | |
| +1.32% | +12.69% | +9.22% | +33.86% | -2.95% | -27.48% | -42.00% | +23.54% | +82.93% | 213B | |
| +0.40% | +4.51% | +3.98% | -0.31% | +7.79% | +25.85% | +55.35% | +45.38% | +140.91% | 190B | |
| -1.05% | +0.06% | -7.83% | -10.43% | +0.90% | +16.91% | +59.86% | +82.44% | +53.90% | 154B | |
| -1.54% | -6.11% | -8.61% | -13.23% | -4.94% | -2.43% | -38.20% | -39.28% | -30.32% | 135B | |
| +1.05% | +6.32% | +10.51% | +5.54% | +5.92% | +7.71% | +38.38% | +147.08% | +486.30% | 122B | |
| +0.71% | +2.57% | -6.84% | -6.02% | +2.69% | +18.66% | -14.84% | -17.01% | -21.56% | 113B | |
| +1.72% | +3.15% | +3.58% | -3.43% | +8.71% | +42.24% | +39.17% | +12.28% | +7.07% | 104B | |
| +0.29% | +0.57% | -4.78% | -7.87% | -10.83% | -10.33% | -25.19% | -16.42% | +6.33% | 101B | |
| -0.46% | -0.74% | -1.21% | -11.32% | -9.09% | -1.17% | +78.43% | +70.43% | +534.19% | 76.71B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +0.89% | +3.34% | +0.77% | -11.92% | +5.46% | +17.03% | +12.12% | +36.12% | +17.33% | 49.4B | |
| -0.42% | +3.35% | +1.23% | -7.50% | -16.00% | -5.50% | +7.84% | -26.48% | +242.54% | 48.71B | |
| +18.72% | +26.51% | +22.36% | +23.26% | +26.99% | +77.96% | -6.93% | -9.25% | -46.37% | 52.57B | |
| Average | +0.75% | +4.09% | +2.08% | +1.27% | +7.82% | +35.59% | +27.11% | +49.91% | +203.48% | 217.61B | |
| Weighted average by Cap. | +1.21% | +4.79% | +4.18% | +8.83% | +5.94% | +31.23% | +58.38% | +126.94% | +439.38% |
- Stock Market
- Stocks
- IRD Stock
- Sector Opus Genetics, Inc.
Select your edition
All financial news and data tailored to specific country editions
